Methicillin-resistant Staphylococcus aureus (MRSA) has been found worldwide and is one of the major nosocomial agents. When MRSA strains were first discovered in hospitals, resistance of MRSA to low concentrations of β-lactams was evident, but increasing resistance to high concentrations of β-lactams is now common. Most of the key elements responsible for methicillin resistance of MRSA have been well defined; however, mechanisms related to the acquisition of those genetic phenotypes in hospitals remain uncertain (4).
Appearance of MRSA resistant to benzalkonium chloride, a disinfectant widely used in hospitals, has been reported (1). To determine if the disinfectant might be related to increases in resistance to β-lactams, we selected strains of MRSA which showed resistance to low concentrations of oxacillin (MIC, 2 to 32 μg/ml), isolated mutants resistant to benzalkonium, and then monitored the resistance to oxacillin. Approximately 2 × 108 cells of parent MRSA were seeded on a Luria-Bertani (LB) agar plate containing 5 μg of benzalkonium chloride per ml and incubated at 37°C for 3 days. The colonies which appeared were isolated as benzalkonium-resistant mutants. The MIC of benzalkonium for parent MRSA was 5 μg/ml, and the value for the isolated mutants increased to 10 μg/ml. Surprisingly, for 15 to 55% of benzalkonium chloride-resistant mutants from these parental strains the MICs of oxacillin were over eightfold higher than the MICs for the parent strains. MRSA strains highly resistant to oxacillin were also obtained with benzethonium chloride, another cationic detergent (data not shown).
Most benzalkonium chloride-resistant mutants with resistance to high concentrations of oxacillin formed small colonies on LB agar. Revertants which formed large colonies showed sensitivity to both benzalkonium chloride and oxacillin, as did the parent MRSA (data not shown). Thus, resistance to oxacillin and resistance to benzalkonium chloride are closely related and may be caused by a single mutation.
Isolation of S. aureus mutants resistant to benzalkonium chloride has been reported (1, 5–7), but a related increase in resistance to β-lactam antibiotics has not been documented. We introduced into a wild type of S. aureus plasmid pTZ20 (6) containing the qacC gene, which is shown to cause resistance to disinfectants. The qacC gene alone increased resistance of S. aureus to benzalkonium chloride but not to β-lactams (data not shown).
MRSA mutants resistant to benzalkonium chloride showed a higher resistance than parent strains to various β-lactam antibiotics including cloxacillin, moxalactam, flomoxef, and cefmetazole (Table 1), as seen in the case of oxacillin. These mutants showed no remarkable increase in resistance to cefazolin and cephalothin (narrow-spectrum cephems), chloramphenicol (an inhibitor of protein synthesis) or ampicillin but did show resistance to ofloxacin, the lethal mechanisms of which differ from those of β-lactams. It is possible that the mutation may affect the efficiency of uptake or may activate an efflux pump of drugs, in a nonspecific manner. Another possibility is that mutation of genes encoding elements regulating the expression of methicillin resistance, such as the femA gene (2), is responsible for the phenotype. Mutations responsible for the concomitant increase in resistance to benzalkonium chloride and β-lactams will need to be identified.
TABLE 1.
Antibiotic | MIC (μg/ml)a
|
||||||
---|---|---|---|---|---|---|---|
MRSAb
|
MSSAc | ||||||
Parent | BZ-R-1 | BZ-R-2 | BZ-R-3 | BZ-R-4 | BZ-R-5 | ||
Oxacillin | 16 | 512 | 512 | 128 | 64 | 64 | 0.3 |
Cloxacillin | 0.5 | 256 | 512 | 128 | 0.5 | 8 | 0.3 |
Moxalactam | 64 | 256 | 1024 | 512 | 256 | 256 | 8 |
Flomoxef | 8 | 128 | 128 | 64 | 16 | 16 | 0.5 |
Cefmetazole | 8 | 128 | 64 | 64 | 32 | 32 | 1 |
Cefazolin | 64 | 128 | 128 | 64 | 128 | 128 | 0.5 |
Cephalothin | 64 | 128 | 128 | 128 | 128 | 128 | 0.5 |
Ampicillin | 16 | 32 | 32 | 16 | 32 | 16 | 0.5 |
Chloramphenicol | 4 | 4 | 4 | 4 | 4 | 4 | 4 |
Ofloxacin | 8 | 32 | 32 | 16 | 16 | 16 | 0.3 |
Tetracycline | 128 | 128 | 128 | 32 | 128 | 128 | NDd |
Kanamycin | 256 | 512 | 512 | 512 | 256 | 256 | ND |
Benzalkonium chloride | 5 | 10 | 10 | 10 | 10 | 10 | 0.7 |
Full growth of bacteria in LB liquid medium was appropriately diluted, and the bacterial suspension (2 × 103) was streaked on LB agar plates containing various concentrations of antibiotics, followed by incubation at 37°C for 72 h.
MRSA strains were examined by identifying the mecA gene by PCR (3) in strains of S. aureus isolated in Kyushu Univeristy Hospital.
MSSA, methicillin-susceptible S. aureus.
ND, not determined.
Acknowledgments
We are grateful to Teruyo Ito, Keiichi Hiramatsu, Masahisa Noguchi, Hiroaki Nakayama, Matsuhisa Inoue, and Yasuyuki Ogata for helpful discussions and for materials.
REFERENCES
- 1.Al-Masaudi S B, Day M J, Russell A D. Sensitivity of methicillin-resistant Staphylococcus aureus strains to some antibiotics, antiseptics and disinfectants. J Appl Bacteriol. 1988;65:329–337. doi: 10.1111/j.1365-2672.1988.tb01899.x. [DOI] [PubMed] [Google Scholar]
- 2.Berger-Bachi B, Barberis-Maino L, Strassle A, Kayser F H. FemA, a host-mediated factor essential for methicillin resistance in Staphylococcus aureus: molecular cloning and characterization. Mol Gen Genet. 1989;219:263–269. doi: 10.1007/BF00261186. [DOI] [PubMed] [Google Scholar]
- 3.Hiramatsu K, Kihara H, Yokota T. Analysis of border line-resistant strains of methicillin resistant Staphylococcus aureus using polymerase chain reaction. Microbiol Immunol. 1992;36:445–453. doi: 10.1111/j.1348-0421.1992.tb02043.x. [DOI] [PubMed] [Google Scholar]
- 4.Hiramatsu K. Molecular evolution of MRSA. Microbiol Immunol. 1995;39:531–543. doi: 10.1111/j.1348-0421.1995.tb02239.x. [DOI] [PubMed] [Google Scholar]
- 5.Paulsen I T, Brown M H, Skurray R A. Proton-dependent multidrug efflux systems. Microbiol Rev. 1996;60:575–608. doi: 10.1128/mr.60.4.575-608.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Sasatsu M, Shibata Y, Tamura S, Kono M. Drug-resistant plasmids in multiply drug-resistant Staphylococcus aureus L20A. Microbios Lett. 1990;43:105–112. [Google Scholar]
- 7.Sasatsu M, Shibata Y, Noguchi N, Kono M. High-level resistance to ethidium bromide and antiseptics in Staphylococcus aureus. FEMS Microbiol Lett. 1992;93:109–114. doi: 10.1016/0378-1097(92)90514-o. [DOI] [PubMed] [Google Scholar]